|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007131,
umls-concept:C0013072,
umls-concept:C0024501,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0064494,
umls-concept:C0087111,
umls-concept:C0205179,
umls-concept:C0205197,
umls-concept:C0205265,
umls-concept:C0205390,
umls-concept:C1518419,
umls-concept:C1554962,
umls-concept:C1555582,
umls-concept:C1696465
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2008-5-5
|
|
pubmed:abstractText |
This study assessed whether maintenance therapy with carboxyaminoimidazole (CAI), compared to placebo, prolonged overall survival in stage IIIB/IV NSCLC patients who had tumour regression or stable disease after treatment with one chemotherapy regimen.
|
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/CA-25224,
http://linkedlifedata.com/resource/pubmed/grant/CA-35101,
http://linkedlifedata.com/resource/pubmed/grant/CA-35103,
http://linkedlifedata.com/resource/pubmed/grant/CA-35113,
http://linkedlifedata.com/resource/pubmed/grant/CA-35119,
http://linkedlifedata.com/resource/pubmed/grant/CA-35195,
http://linkedlifedata.com/resource/pubmed/grant/CA-35269,
http://linkedlifedata.com/resource/pubmed/grant/CA-35431,
http://linkedlifedata.com/resource/pubmed/grant/CA-35448,
http://linkedlifedata.com/resource/pubmed/grant/CA-37404,
http://linkedlifedata.com/resource/pubmed/grant/CA-37417,
http://linkedlifedata.com/resource/pubmed/grant/CA-60276,
http://linkedlifedata.com/resource/pubmed/grant/CA-63848,
http://linkedlifedata.com/resource/pubmed/grant/CA-63849
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0169-5002
|
|
pubmed:author |
pubmed-author:AdjeiAlex AAA,
pubmed-author:BaumanMitchel DMD,
pubmed-author:BernathAlbert MAMJr,
pubmed-author:FitchTom RTR,
pubmed-author:GrahamDavid LDL,
pubmed-author:HaugeMark DMD,
pubmed-author:HillmanShauna LSL,
pubmed-author:JettJames RJR,
pubmed-author:JohnsonElizabeth AEA,
pubmed-author:KuglerJohn WJW,
pubmed-author:MandrekarSumithra JSJ,
pubmed-author:MarksRandolph SRS,
pubmed-author:MooreDennis FDF,
pubmed-author:PerezEdith AEA,
pubmed-author:SooriGamini SGS,
pubmed-author:WindschitlHarold EHE,
pubmed-author:WosEdward JEJ
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
60
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
200-7
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18045731-Aged,
pubmed-meshheading:18045731-Antineoplastic Agents,
pubmed-meshheading:18045731-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:18045731-Double-Blind Method,
pubmed-meshheading:18045731-Female,
pubmed-meshheading:18045731-Humans,
pubmed-meshheading:18045731-Kaplan-Meier Estimate,
pubmed-meshheading:18045731-Lung Neoplasms,
pubmed-meshheading:18045731-Male,
pubmed-meshheading:18045731-Middle Aged,
pubmed-meshheading:18045731-Placebos,
pubmed-meshheading:18045731-Quality of Life,
pubmed-meshheading:18045731-Triazoles
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51).
|
|
pubmed:affiliation |
Mayo Clinic Jacksonville, Jacksonville, FL 32224, USA. johnson.elizabeth2@mayo.edu
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study,
Clinical Trial, Phase III,
Research Support, N.I.H., Extramural
|
